ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

ClinicalTrials.gov ID: NCT06776783

Public ClinicalTrials.gov record NCT06776783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 5:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Controlled, Blinded, Parallel Group Study of the Safety and Efficacy of APC-0101 (SF-RI 1 Surfactant for Inhalation Combined With a Dedicated Delivery System) in Preterm Infants With Respiratory Distress Syndrome

Study identification

NCT ID
NCT06776783
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aerogen Pharma Limited
Industry
Enrollment
520 participants

Conditions and interventions

Interventions

  • APC-0101 (SF-RI 1 surfactant for inhalation combined with a dedicated delivery system) Combination Product
  • Control Other

Combination Product · Other

Eligibility (public fields only)

Age range
1 Hour to 24 Hours
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 23, 2025
Primary completion
Apr 30, 2027
Completion
Apr 30, 2029
Last update posted
Apr 13, 2026

2025 – 2029

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 Recruiting
Jacobs Medical Center La Jolla California 92037 Recruiting
UF Health Jacksonville Jacksonville Florida 32209 Recruiting
Advent Health Orlando Florida 32803 Recruiting
Memorial Hospital of South Bend South Bend Indiana 46601 Recruiting
Goryeb Children's Hospital Morristown New Jersey 07960 Recruiting
The Trustees of Columbia University in the City of New York New York New York 10032 Recruiting
Montefiore Medical Center The Bronx New York 10461 Recruiting
Maria Farreri Children's Hospital Valhalla New York 10595 Recruiting
Christus Children's Hospital San Antonio Texas 78207 Recruiting
University of Virginia School of Medicine Charlottesville Virginia 22903 Recruiting
WVU Medicine Children's Hospital Morgantown West Virginia 26506 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06776783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06776783 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →